The role of calcitonin gene-related peptide on the increase in transient receptor potential vanilloid-1 levels in trigeminal ganglion and trigeminal nucleus caudalis activation of rat

Journal of Chemical Neuroanatomy

Volumn 47, Issue , 2013, Pages 50-56

  Chatchaisak, Duangthip ^a   Srikiatkhachorn, Anan ^b   Grand, Supang Maneesri le ^b   Govitrapong, Piyarat ^a,c   Chetsawang, Banthit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c NONE   (Thailand)

Author keywords

C Fos; CGRP; Migraine; Trigeminal ganglion; Trigeminal nucleus caudalis; TRPV1

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN C FOS; PROTEIN KINASE C; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; IMMUNOHISTOCHEMISTRY; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SENSITIZATION; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION;

ANIMALS; BLOTTING, WESTERN; CALCITONIN GENE-RELATED PEPTIDE; IMMUNOHISTOCHEMISTRY; MALE; PAIN; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRIGEMINAL CAUDAL NUCLEUS; TRIGEMINAL GANGLION; TRPV CATION CHANNELS;

EID: 84873255075     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2012.09.005     Document Type: Article

References (39)

1. Asghar M.S., Hansen A.E., Larsson H.B., Olesen J., Ashina M. Effect of CGRP and sumatriptan on the BOLD response in visual cortex. Journal of Headache Pain 2012, 13:159-166.
2. Bae Y.C., Oh J.M., Hwang S.J., Shigenaga Y., Valtschanoff J.G. Expression of vanilloid receptor TRPV1 in the rat trigeminal sensory nuclei. Journal of Comparative Neurology 2004, 478:62-71.
3. Brain S.D., Grant A.D. Vascular action of calcitonin gene-related peptide and adrenomedullin. Physiological Reviews 2004, 84:903-934.
4. Cady R.J., Glenn J.R., Smith K.M., Durham P.L. Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization. Molecular Pain 2011, 7:1-11.
5. 2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma (OHS-4). Cytokine 1999, 11:200-207.
6. Durham P.L. CGRP receptor antagonists: a new choice for acute treatment of migraine?. Current Opinion in Investigational Drugs 2004, 5:731-735.
7. Durham P.L., Garrett F.G. Emerging importance of neuron-satellite glia interactions within trigeminal ganglia in craniofacial pain. The Open Pain Journal 2010, 3:3-13.
8. Edvinsson L., Goadsby P.J. Neuropeptides in the cerebral circulation: relevance to migraine. Cephalalgia 1995, 15:272-276.
9. Edvinsson L., Uddman R. Neurobiology in primary headaches. Brain Research Reviews 2005, 48:438-456.
10. Fan P.C., Kuo P.H., Chang S.H., Lee W.T., Wu R.M., Chiou L.C. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine. Cephalalgia 2009, 29:883-890.
11. Fusayasu E., Kowa H., Takeshima T., Nakaso K., Nakashima K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 2007, 128:209-214.
12. Goadsby P.J., Charbit A.R., Andreou A.P., Akerman S., Holland P.R. Neurobiology of migraine. Neuroscience 2009, 161:327-341.
13. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Annals of Neurology 1990, 28:183-187.
14. Greco R., Tassorelli C., Sandrini G., Bella P.D., Buscone S., Nappi G. Role of calcitonin gene-related peptide and substance P in different models of pain. Cephalalgia 2007, 28:114-126.
15. Hansen J.M., Hauge A.W., Olesen J., Ashina M. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 2010, 30:1179-1186.
16. Jenkins D.W., Langmead C.J., Parsons A.A., Strijbos P.J. Regulation of calcitonin gene-related peptide release from rat trigeminal nucleus caudalis slices in vitro. Neuroscience Letters 2009, 366:241-244.
17. Jeske N.A., Patwardhan A.M., Ruparel N.B., Akopian A.N., Shapiro M.S., Henry M.A. A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1. Pain 2009, 146:301-307.
18. Koulchitsky S., Fischer M.J., Messlinger K. Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus. Cephalagia 2008, 29:408-417.
19. Lassen L.H., Jacobsen V.B., Haderslev P.A., Sperling B., Iversen H.K., Olesen J., Tfelt-Hansen P. Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. Journal of Headache Pain 2008, 6:151-157.
20. Lazarov N.E. Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus. Progress in Neurobiology 2002, 66:19-59.
21. Lennerz J.K., Rühle V., Ceppa E.P., Neuhuber W.L., Bunnett N.W., Grady E.F., Messlingr K. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. Journal of Comparative Neurology 2008, 507:1277-1299.
22. Mitsikostas D.D., Sanchez del Rio M. Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Research. Brain Research Reviews 2001, 35:20-35.
23. Moskowitz M.A., Nozaki K., Kraig R.P. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. Journal of Neuroscience 1993, 13:1167-1177.
24. Nicoletti P., Trevisani M., Manconi M., Gatti R., Siena C.D., Zagli G., Benemei S., Capone J.A. Ethanol cause neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia 2008, 28:9-17.
25. Olesen J., Diener H.C., Husstedt I.W., Goadsby P.J., Hall D., Meier U., Pollentier S., Lesko L.M. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. New England Journal of Medicine 2004, 350:1104-1110.
26. Petersen K.A., Nilsson E., Olesen J., Edvinsson L. Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo. Cephalalgia 2005, 25:424-432.
27. Petersen K.A., Lassen L.H., Birk S., Lesko L., Olesen J. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilation. Clinical Pharmacology and Therapeutics 2005, 3:202-213.
28. Price T.J., Flores C.M. Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities and isolectin B4 binding in primary afferent neurons of the rat and mouse. Journal of Pain 2007, 8:263-272.
29. Rusu M.C. The spinal trigeminal nucleus-considerations on the structure of the nucleus caudalis. Folia Morphologica 2004, 63:325-328.
30. Simonetti M.L., Giniatullin R., Fabbretti E. Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons. Journal of Biological Chemistry 2008, 283:18743-18752.
31. Sixt M.L., Messlinger K., Fischer M.J. Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain 2009, 132:3134-3141.
32. Storer R.J., Akerman S., Goadsby P.J. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. British Journal of Pharmacology 2004, 142:1171-1181.
33. Sun R.Q., Tu Y.J., Lawand N.B., Yan J.Y., Lin Q., Willis W.D. Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization. Journal of Neurophysiology 2004, 92:2859-2866.
34. Thalakoti S., Patil V.V., Damodaram S., Vause C.V., Langford L.E., Freeman S.E., Durham P.L. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 2007, 47:1008-1023.
35. Tominaga M., Tominaga T. Structure and function of TRPV1. European Journal of Physiology 2005, 451:143-150.
36. Vause C.V., Durham P.L. CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogen-activated protein kinase pathways. Journal of Neurochemistry 2009, 110:811-821.
37. Vetter I., Wyse B.D., Roberts-Thomson S.J., Monteith G.R., Cabot P.J. Mechanisms involved in potentiation of transient receptor potential vanilloid1 responses by ethanol. European Journal of Pain 2008, 12:441-454.
38. Xu X., Wang P., Zou X., Li D., Fang L., Lin Q. Increases in transient receptor potential vanilloid-1 mRNA and protein in primary afferent neurons stimulated by protein kinase C and their possible role in neurogenic inflammation. Journal of Neuroscience Research 2009, 87:482-494.
39. Zhang Z., Winborn C.S., Marquez de Prado B., Russo A.F. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. Journal of Neuroscience 2007, 27:2693-2703.